Patient-to-Patient: What to Expect in a Clinical Trial
Janet Freeman-Daily, patient advocate and CURE contributor, discusses some key points that patients should know about enrolling in clinical trials.
Janet Freeman-Daily, patient advocate and CURE contributor, discusses some key points that patients should know about enrolling in clinical trials.
Freeman-Daily says that clinical trials are especially important for patients like her who have metastatic lung cancer, for which there is currently no cure but a number of options and clinical trials that may benefit patients.
Before joining a clinical trial, patients should know their risk and understand the difference between each of the three phases of clinical trials. Also, patients should never think that they may not be treated in a clinical trial. Even if randomized to placebo, they will always get the best standard of care.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More
